66183067HM017L0health economic evaluation,health technology assessment,medical innovation,research and development,target product profiles

การจัดกระบวนการพัฒนาชุดสิทธิประโยชน์แบบครบวงจร ภายใต้ระบบหลักประกันสุขภาพแห่งชาติ เป็นการดำเนินงานตามที่ได้รับมอบหมายจ

Over the past two decades a notable progression has been made in relation to the capacity building of health technology assessment (HTA ) research and its policy utility in Thailand. Such developments have been shaped by multiple factors. This study aims to review 20 years experiences of an attempt to establish a  formal HTA system in Thailand, fo

This study aims to review public information concerning Human papillomavirus (HPV) vaccine that was disseminated through printing media in Thailand. It also examines the knowledge and decision to get vaccinated among people who had exposed and not exposed to the information. Media analysis was performed on articles published in popular health, wome

At present time, there is an increasing impetus to use laparoscopic surgery (LS) or minimally invasive surgery for the diagnosis and treatment of disease. Empirical evidence, however, has demostrated an unequal access to LS amongst the different types of patients\' health insurance schemes(i.e. CSMBS, UC) in Thailand. Therefore, this study aims to

Economic evaluation of HLA-B*1502 screening for preventing carbamazepine- induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) is prioritized by stakeholders under ‘Research for development of health benefit package under universal coverage scheme’. The study carried out an evidence to inform the Subcommittee for Developm

Introduction: The development of new technology to treat patients with metastatic renal cell carcinoma has resulted in promising outcomes in terms of extending life and improving quality of life. In Thailand, where health resources are limited, an economic evaluation of such technology would provide useful information for pricing and reimbursement

Patients who are using warfarin, an oral anticoagulant with narrow therapeutic index, needs to be followed up regularly. The index that has been used to monitor the result of using the medicine is International Normalized Ratio (INR). The gold standard of the method to measure INR is to measure using a specific device in the laboratory. However, th